Oral feeding of renal tubular antigen abrogates interstitial nephritis and renal failure in Brown Norway rats

Kidney International

Volumn 52, Issue 3, 1997, Pages 725-732

  Pham, Kevin ^b   Smoyer, William E ^b   Archer, D Clay ^b   Gabbai, Francis ^b   Kelly, Carolyn J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Antigens; Autoimmune disease; Interstitial nephritis; Oral feeding in TIN; Renal failure

Indexed keywords

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; IMMUNIZATION; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030866614     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.388     Document Type: Article

References (53)

1. WELLS H: Studies on the chemistry of anaphylaxis. III. Experiments with isolated proteins, especially those of hen's egg. J Infect Dis 9:147-151, 1911
2. CHASE MW: Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med 61:257-259, 1946
3. WEINER HL, FRIEDMAN A, MILLER A, KHOURY SJ, AL-SABBAGH A, SANTOS L, SAYEGH M, NUSSENBLATT RB, TRENTHAM DE, HAFLER DA: Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 12:809-837, 1994
4. BITAR DM, WHITACRE CC: Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell Immunol 112:364-370, 1988
5. HIGGINS PJ, WEINER HL: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 140:440-445, 1988
6. WANG Z-Y, QIAO L, LINK H: Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. J Neuroimmunol 44:209-214, 1993
7. NUSSENBLATT RB, CASPI RR, MAHDI R, CHAN CC, ROBERGE F, LIDER O, WEINER HL: Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 144:1689-1695, 1990
8. NAGLER-ANDERSON C, BOBER LA, ROBINSON ME, SISKIND GW, THORBECKE FJ: Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA 83:7443-7446, 1986
9. KELLY CJ, CLAYMAN MD, NEILSON EG: Immunoregulation in experimental interstitial nephritis: Immunization with renal tubular antigen in incomplete Freund's adjuvant induces major histocompatibility restricted OX8+ suppressor T cells which are antigen specific and inhibit the expression of disease. J Immunol 136:903-907, 1986
10. NEILSON EG, PHILLIPS SM: Cell-mediated immunity in interstitial nephritis. I. T lymphocyte systems in nephritis guinea pigs: The natural history and diversity of the immune response. J Immunol 123:2373-2380, 1979
11. NEILSON EG, PHILLIPS SM: Murine interstitial nephritis I. Analysis of disease susceptibility and its relationship to pleiomorphic gene products defining both immune response genes and restrictive requirement for cytotoxic T cells at H-2K. J Exp Med 155:1075-1085, 1982
12. MAMPASO FM, WILSON CB: Characterization of inflammatory cells in autoimmune tubulointerstitial nephritis in rats. Kidney Int 23:448-457, 1983
13. KELLY CJ, ROTH DA, MEYERS CM: Immune recognition and response to the renal interstitium. Kidney Int 31:518-530, 1991
14. STEBLAY RW, RUDOFSKY U: Transfer of experimental autoimmune renal cortical tubular and interstitial disease in guinea pigs by serum. Science 180:966-968, 1973
15. VAN ZWIETEN M, BHAN A, MCCLUSKEY R, COLLINS A: Studies on the pathogenesis of experimental anti-tubular basement membrane nephritis in the guinea pig. Am J Pathol 83:531-546, 1976
16. BANNISTER K, WILSON C: Transfer of tubulointerstitial nephritis in the Brown Norway rat with anti-tubular basement membrane antibody: Quantitation and kinetics of binding and effect of decomplementation. J Immunol 135:3911-3917, 1985
17. NEILSON EG, GASSER DL, MCCAFFERTY E, ZAKHEIM B, PHILLIPS SM: Polymorphism of genes involved in anti-tubular basement membrane disease in rats. Immunogenetics 17:555-565, 1983
18. KELLY CJ, MOK H, NEILSON EG: The selection of effector T cell phenotype by contrasuppression modulates susceptibility to autoimmune injury. J Immunol 141:3022-3028, 1988
19. + regulatory T cells. J Immunol 136: 4200-4208, 1987
20. NEILSON EG, MCCAFFERTY E, MANN R, MICHAUD L, CLAYMAN M: Murine interstitial nephritis. III. The selection of phenotypic (Lyt and L3T4) and idiotypic (RE-Id) T cell preferences by genes in Igh-1 and H-2K characterize the cell-mediated potential for disease expression: Susceptible mice provide a unique effector T cell repertoire in response to tubular antigen. J Immunol 134:2375-2382, 1985
21. AGUS D, MANN R, CLAYMAN M, KELLY C, MICHAUD L, COHN D, NEILSON EG: The effects of daily cyclophosphamide administration on the development and extent of primary experimental interstitial nephritis in rats. Kidney Int 29:635-640, 1986
22. SHIH W, HINES W, NEILSON EG: Effects of cyclosporin A on the development of immune-mediated interstitial nephritis. Kidney Int 33:1113-1118, 1988
23. AGUS D, MANN R, COHN D, MICHAUD L, KELLY C, CLAYMAN M, NEILSON EG: Inhibitory role of dietary protein restriction on the development and expression of immune-mediated antitubular basement membrane-induced tubulointerstitial nephritis in rats. J Clin Invest 76:930-936, 1985
24. KELLY CJ, ZURIER RB, KRAKAUER KA, BLANCHARD N, NEILSON EG: Prostaglandin E1 inhibits effector T cell induction and tissue damage in experimental murine interstitial nephritis. J Clin Invest 79:782-789, 1987
25. KELLY CJ, CLAYMAN MD, HINES WH, NEILSON EG: Therapeutic immune regulation in experimental interstitial nephritis with suppressor T cells and their soluble factors. Ciba Found Symp 129:73-87, 1987
26. KELLY CJ, NEILSON EG: Contrasuppression in autoimmunity. Abnormal contrasuppression facilitates expression of nephritogenic effector T cells and interstitial nephritis in kdkd mice. J Exp Med 165:107-123, 1987
27. NEILSON EG, MCCAFFERTY E, MANN R, MICHAUD L, CLAYMAN M: Tubular antigen derivatized cells induce a disease protective, antigen-specific, and idiotype-specific suppressor T cell network restricted by IJ and Igh-V in mice with experimental interstitial nephritis. J Exp Med 162:215-230, 1985
28. NEILSON EG, KELLY CJ, CLAYMAN MD, HINES WH, HAVERTY T, SUN MJ, BLANCHARD N: Murine interstitial nephritis. VII. Suppression of renal injury after treatment with soluble suppressor factor TsF1. J Immunol 139:1518-1524, 1987
29. KELLY CJ, SILVERS W, NEILSON EG: Tolerance to parenchymal self: The regulatory role of an RT1-restricted, OX8+ suppressor T cell for autologous renal tubular antigen in experimental interstitial nephritis. J Exp Med 162:1892-1903, 1985
30. + Tcrα-β-lymphocytes (putative γ/δ T cells). Immunology 74:234-239, 1991
31. DICK AD, CHENG YF, MCKINNON A, LIVERSIDGE J, FORRESTER JV: Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Br J Ophthalmol 77:171-175, 1993
32. DEVEY ME, BLEASDALE K: Antigen feeding modifies the course of antigen-induced immune complex disease. Clin Exp Immunol 56:637-644, 1984
33. GESUALDO L, LAMM ME, EMANCIPATOR SN: Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization. J Immunol 145:3684-3691, 1990
34. MILLER A, LIDER O, ROBERTS AB, SPRON MB, WEINER HL: Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. PNAS USA 89:421-425, 1992
35. LIDER O, SANTOS LMB, LEE CSY, HIGGINS PJ, WEINER HL: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J Immunol 142:748-752, 1989
36. MILLER A, AL-SABBAGH A, SANTOS LM, DAS MP, WEINER HL: Epitopes of myelin basic protein that trigger TGF-heta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol 151:7307-7315, 1993
37. CHEN Y, KUCHROO VK, INOBE J, HAFLER DA, WEINER HL: Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 265:1237-1240, 1994
38. VAN HOUTEN N, BLAKE SF: Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J Immunol 157:1337-1341, 1996
39. + effector T cell that mediates destructive tubulointerstitial injury. J Immunol 136:526-531, 1986
40. MEYERS CM, KELLY CJ: Effector mechanisms in organ-specific autoimmunity. I. Characterization of a CD8+ T cell line that mediates murine interstitial nephritis. J Clin Invest 88:408-416, 1991
41. MEYERS CM, KELLY CJ: Adoptive transfer of an antigen-specific DTH-reactive T cell clone induces murine interstitial nephritis. (abstract) J Am Soc Nephrol 2:553, 1991
42. SCHAINUCK LI, STRIKER GE, CUTLER RE, BENDITT EP: Structural-functional correlations in renal disease. Hum Pathol 1:631-641, 1970
43. BOHLE A, MACKENSEN-HAEN S, VON GISE H: Significance of tubuloinerstitial changes in the renal cortex for excretory function and concentration ability of the kidney: A morphometric contribution. Am J Nephrol 7:421-433, 1987
44. BOHLE A, MACKENSEN-HAEN S, VON GISE H, GRUND KE, WEHRMANN M, BATZ C, BOGENSCHUTZ O, SCHMITT H, NAGY J, MULLER C, MULLER G: The consequences of tubulo-interstitial changes for renal function in glomerulopathies. Path Res Pract 186:135-144, 1990
45. MEYERS CM, KELLY CJ: Immunoregulation and TGF-β1. Suppression of a nephritogenic murine T cell clone Kidney Int 46:1295-1301, 1994
46. MEYERS CM, KELLY CJ: Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factor. J Clin Invest 94:2093-2104, 1994
47. BAILEY NC, FRISHBERG Y, KELLY CJ: Loss of high affinity TGF-β1 binding to a nephritogenic T cell results in absence of growth inhibition by TGF-β1 and augmented nephritogenicity. J Immunol 156:3009-3016, 1996
48. CLAYMAN MD, MARTINEZ-HERNANDEZ A, MICHAUD L, ALPER R, MANN R, KEFALIDES NA, NEILSON EG: Isolation and characterization of the nephritogenic antigen producing anti-tubular basement membrane disease. J Exp Med 161:290-305, 1985
49. AL-SABBAGH A, MILLER A, SANTOS LM, WEINER HL: Antigen-driven tissue-specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur J Immunol 24:2104-2109, 1994
50. SUN JB, HOLMGREN J, CZERKINSKY C: Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci USA 91:10795-10799, 1994
51. WEINER HL, MACKIN GA, MATSUI M, ORAV EJ, KHOURY SJ, DAWSON DM, HAFLER DA: Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259:1321-1324, 1993
52. TRENTHAM DE, DYNESIUS-TRENTHAM RA, ORAV EJ, COMBITCHI D, LORENZO C, SEWELL KL, HAFLER DA, WEINER HL: Effects of oral administration of collagen on rheumatoid arthritis. Science 261:1727-1730, 1993
53. GENAIN C, ABEL K, BELMAR N, VILLINGER F, ROSENBERG D, LININGTON C, RAINE C, HAUSER S: Late complications of immune deviation therapy in a nonhuman primate. Science 274:2054-2057, 1996